Bouffard DY - Search Results

1

Pilot phase I-II study on 5-aza-2'-deoxycytidine (Decitabine) in patients with metastatic lung cancer.

Momparler RL, Bouffard DY, Momparler LF, Dionne J, Belanger K, Ayoub J. Momparler RL, et al. Among authors: bouffard dy. Anticancer Drugs. 1997 Apr;8(4):358-68. doi: 10.1097/00001813-199704000-00008. Anticancer Drugs. 1997. PMID: 9180389 Clinical Trial.

2

Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.

Damaraju VL, Bouffard DY, Wong CK, Clarke ML, Mackey JR, Leblond L, Cass CE, Grey M, Gourdeau H. Damaraju VL, et al. Among authors: bouffard dy. BMC Cancer. 2007 Jul 3;7:121. doi: 10.1186/1471-2407-7-121. BMC Cancer. 2007. PMID: 17608948 Free PMC article.

3

Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.

Bouffard DY, Jolivet J, Leblond L, Hamelin B, Ouellet F, Barbeau S, Richard A, Gourdeau H. Bouffard DY, et al. Cancer Chemother Pharmacol. 2003 Dec;52(6):497-506. doi: 10.1007/s00280-003-0699-4. Epub 2003 Sep 3. Cancer Chemother Pharmacol. 2003. PMID: 12955470

4

Comparison of the induction of apoptosis in human leukemic cell lines by 2',2'-difluorodeoxycytidine (gemcitabine) and cytosine arabinoside.

Bouffard DY, Momparler RL. Bouffard DY, et al. Leuk Res. 1995 Nov;19(11):849-56. doi: 10.1016/0145-2126(95)00067-4. Leuk Res. 1995. PMID: 8551802

5

Kinetic studies on 2',2'-difluorodeoxycytidine (Gemcitabine) with purified human deoxycytidine kinase and cytidine deaminase.

Bouffard DY, Laliberté J, Momparler RL. Bouffard DY, et al. Biochem Pharmacol. 1993 May 5;45(9):1857-61. doi: 10.1016/0006-2952(93)90444-2. Biochem Pharmacol. 1993. PMID: 8494545

6

Enhancement of the antileukemic activity of 5-aza-2'-deoxycytidine by cyclopentenyl cytosine in HL-60 leukemic cells.

Bouffard DY, Momparler LF, Momparler RL. Bouffard DY, et al. Anticancer Drugs. 1994 Apr;5(2):223-8. doi: 10.1097/00001813-199404000-00014. Anticancer Drugs. 1994. PMID: 7519483

7

Cellular pharmacology of 1-beta-D-arabinofuranosylcytosine in human myeloid, B-lymphoid and T-lymphoid leukemic cells.

Momparler RL, Onetto-Pothier N, Bouffard DY, Momparler LF. Momparler RL, et al. Among authors: bouffard dy. Cancer Chemother Pharmacol. 1990;27(2):141-6. doi: 10.1007/BF00689099. Cancer Chemother Pharmacol. 1990. PMID: 2249330

8

Enhancement of anti-neoplastic activity of cytosine arabinoside against human HL-60 myeloid leukemic cells by 3-deazauridine.

Momparler RL, Bouffard DY, Momparler LF, Marquet J, Zittoun J, Marie JP, Zittoun R. Momparler RL, et al. Among authors: bouffard dy. Int J Cancer. 1991 Oct 21;49(4):573-6. doi: 10.1002/ijc.2910490417. Int J Cancer. 1991. PMID: 1917159

9

Comparison of antineoplastic activity of 2',2'-difluorodeoxycytidine and cytosine arabinoside against human myeloid and lymphoid leukemic cells.

Bouffard DY, Momparler LF, Momparler RL. Bouffard DY, et al. Anticancer Drugs. 1991 Feb;2(1):49-55. doi: 10.1097/00001813-199102000-00007. Anticancer Drugs. 1991. PMID: 1958852

10

Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.

Gourdeau H, Genne P, Kadhim S, Bibeau L, Duchamp O, Ouellet F, deMuys JM, Bouffard DY, Attardo G. Gourdeau H, et al. Among authors: bouffard dy. Cancer Chemother Pharmacol. 2002 Dec;50(6):490-6. doi: 10.1007/s00280-002-0530-7. Epub 2002 Oct 16. Cancer Chemother Pharmacol. 2002. PMID: 12451476

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results